Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baogongzhixue Granules
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Baogongzhixue Granules is a proprietary Traditional Chinese Medicine (TCM) developed and marketed by Guizhou Yibai Pharmaceutical. It is primarily indicated for the treatment of uterine bleeding, including hemorrhage following induced abortion, postpartum bleeding, and dysfunctional uterine bleeding. The formulation is composed of several herbal extracts, including *Radix Sanguisorbae* (Diyu), *Herba Leonuri* (Yimucao), *Radix Astragali* (Huangqi), and *Radix Angelicae Sinensis* (Danggui). These components work synergistically to tonify Qi, cool the blood, and resolve blood stasis, thereby promoting uterine contraction and facilitating hemostasis. The product is administered orally and is widely used in clinical practice in China for gynecological recovery.
- Brand names
- Baogongzhixue Granules
- Other names
- Baogong Zhixue Keli保宫止血颗粒
Beyond the preview
Go deeper on Baogongzhixue Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baogongzhixue Granules.